A carregar...
Dapagliflozin as an adjunct therapy to insulin in the treatment of patients with type 1 diabetes mellitus
We have evaluated the efficacy of dapagliflozin in patients with type 1 diabetes mellitus (DM1) without adequate control. We expected that adding dapagliflozin to this population on top of their base treatment would lower their HbA1c levels. We conducted a pragmatic, open, 24-week study of treatment...
Na minha lista:
| Publicado no: | J Diabetes Metab Disord |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4600276/ https://ncbi.nlm.nih.gov/pubmed/26457255 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40200-015-0210-x |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|